— Know what they know.
Not Investment Advice

NTRA NASDAQ

Natera, Inc.
1W: -0.5% 1M: +26.2% 3M: +44.6% YTD: +79.3% 1Y: +153.9% 3Y: +780.2% 5Y: +247.4%
$410.35
+1.88 (+0.46%)
 
Weekly Expected Move ±5.1%
$369 $390 $410 $431 $452
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 70 · $58.8B mcap · 137M float · 1.06% daily turnover · Short 50% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
61.2 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -23.6%  ·  5Y Avg: 73.5%
Cost Advantage
50
Intangibles
73
Switching Cost
46
Network Effect
85
Scale
58
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. NTRA has a Narrow competitive edge (61.2/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. Negative ROIC of -23.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$284
Low
$369
Avg Target
$475
High
Based on 14 analysts since Aug 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 25Hold: 3Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$359.24
Analysts17
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-01 Guggenheim — $360 $475 +115 +13.6% $418.12
2026-09-25 RBC Capital — $350 $460 +110 +12.3% $409.70
2026-09-09 UBS — $260 $435 +175 +34.2% $324.14
2026-09-08 Redburn Partners — Initiated $385 — +17.3% $328.18
2026-08-12 Stephens — $54 $350 +296 +10.3% $317.25
2026-08-12 Guggenheim — $290 $360 +70 +15.1% $312.72
2026-08-10 Morgan Stanley — $310 $355 +45 +9.7% $323.58
2026-08-07 RBC Capital — $275 $350 +75 +10.7% $316.14
2026-08-07 Robert W. Baird Catherine Ramsey Schulte $265 $348 +83 +31.1% $265.38
2026-08-07 Canaccord Genuity Kyle Mikson $330 $375 +45 +41.3% $265.38
2026-08-07 Wells Fargo — $220 $284 +64 +7.0% $265.38
2026-08-07 BTIG — $275 $320 +45 +20.6% $265.38
2026-08-07 Leerink Partners — Initiated $330 — +24.3% $265.38
2026-08-07 Barclays — $270 $340 +70 +28.1% $265.38
2026-07-14 Canaccord Genuity — $285 $330 +45 +20.9% $272.89
2026-07-09 Morgan Stanley — $265 $310 +45 +13.0% $274.39
2026-07-06 Evercore ISI — $270 $300 +30 +6.7% $281.26
2026-06-29 Guggenheim Subbu Nambi $270 $290 +20 +10.7% $261.91
2026-06-24 BTIG — $270 $275 +5 +5.5% $260.72
2026-06-24 UBS — $280 $260 -20 +10.8% $234.76
2026-06-23 BTIG — $125 $270 +145 +15.0% $234.76
2026-06-11 RBC Capital Dan Leonard $268 $275 +7 +25.4% $219.23
2026-06-05 Goldman Sachs Evie Koslosky $80 $245 +165 +10.3% $222.10
2026-05-12 Piper Sandler — $150 $249 +99 +25.0% $199.14
2026-05-08 Robert W. Baird — $160 $265 +105 +31.8% $201.13
2026-05-08 Evercore ISI — Initiated $270 — +34.9% $200.20
2026-05-08 Wells Fargo Brandon Couillard $205 $220 +15 +0.1% $219.82
2026-01-05 Guggenheim — $129 $270 +141 +17.1% $230.65
2025-12-22 Canaccord Genuity — $195 $285 +90 +22.9% $231.96
2025-12-15 Wells Fargo — $175 $205 +30 -11.6% $231.88
2025-12-15 Barclays — Initiated $270 — +16.4% $231.88
2025-12-01 Morgan Stanley — $195 $265 +70 +13.1% $234.25
2025-11-18 UBS — Initiated $280 — +31.1% $213.65
2025-10-27 BNP Paribas Navann Ty Initiated $172 — -10.6% $192.35
2025-09-22 Wells Fargo Brandon Couillard Initiated $175 — -3.4% $181.11
2025-09-02 RBC Capital Conor McNamara Initiated $268 — +58.3% $169.34
2025-08-10 Morgan Stanley Patrick Wood $132 $195 +63 +28.3% $151.95
2025-02-28 Canaccord Genuity — $150 $195 +45 +25.3% $155.59
2024-11-13 Jefferies Tycho Peterson $142 $182 +40 +58.9% $114.57
2024-11-13 Robert W. Baird Catherine Ramsey Schulte $120 $160 +40 +39.7% $114.57
2024-10-29 Canaccord Genuity Kyle Mikson $145 $150 +5 +24.3% $120.71
2024-09-13 Piper Sandler Dave Westenberg $120 $150 +30 +19.9% $125.12
2024-08-27 Canaccord Genuity Kyle Mikson Initiated $145 — +22.8% $118.11
2024-08-13 Morgan Stanley Tejas Savant Initiated $132 — +14.5% $115.25
2024-08-09 Robert W. Baird Catherine Ramsey Schulte $117 $120 +3 +11.4% $107.70
2024-06-25 Wolfe Research Doug Schenkel Initiated $135 — +25.7% $107.41
2024-06-03 Jefferies Tycho Peterson Initiated $142 — +33.3% $106.53
2024-05-14 Piper Sandler David Westenberg $70 $120 +50 +16.1% $103.33
2024-05-13 BTIG Mark Massaro Initiated $125 — +18.7% $105.29
2024-05-10 Robert W. Baird Catherine Ramsey Schulte Initiated $117 — +22.4% $95.55

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
2
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. NTRA receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (2/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-10-01 C- D+
2026-05-06 D+ C-
2026-04-01 C- D+
2026-01-03 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 50 Grade D
Profitability
19
Balance Sheet
36
Earnings Quality
29
Growth
87
Value
32
Momentum
79
Safety
100
Cash Flow
23
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. NTRA scores highest in Safety (100/100) and lowest in Profitability (19/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
27.59
Safe Zone
Piotroski F-Score
6/9
✗ ✓ ✓ ✓ ✓ ✗ ✗ ✓ ✓
Beneish M-Score
0.43
Possible Manipulator
Ohlson O-Score
-8.94
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A
Score: 72.9/100
Trend: Stable
Earnings Quality
—
OCF/NI: -1.19x
Accruals: -19.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. NTRA scores 27.59, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. NTRA scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. NTRA's score of 0.43 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. NTRA's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. NTRA receives an estimated rating of A (score: 72.9/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-301.73x
PEG
-18.59x
P/S
21.71x
P/B
32.28x
P/FCF
542.46x
P/OCF
170.41x
EV/EBITDA
-212.35x
EV/Revenue
14.05x
EV/EBIT
-155.58x
EV/FCF
530.57x
Earnings Yield
-0.49%
FCF Yield
0.18%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. NTRA currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.761
NI / EBT
×
Interest Burden
1.033
EBT / EBIT
×
EBIT Margin
-0.090
EBIT / Rev
×
Asset Turnover
1.226
Rev / Assets
×
Equity Multiplier
1.439
Assets / Equity
=
ROE
-12.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. NTRA's ROE of -12.5% is driven by Asset Turnover (1.226), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$410.35
Median 1Y
$497.66
5th Pctile
$171.49
95th Pctile
$1446.68
Ann. Volatility
61.7%
Analyst Target
$359.24
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Steven Chapman
Chief Executive Officer and President ​
$853,710 $12,979,558 $14,957,319
Matthew Rabinowitz
Executive Chairman ​
$426,434 $10,383,434 $11,283,382
Michael Brophy
Chief Financial Officer ​
$562,794 $4,500,844 $5,460,022
Solomon Moshkevich
President, Clinical Diagnostics
$504,652 $4,500,844 $5,367,000
John Fesko
President, Chief Business Officer
$504,652 $4,186,634 $5,052,790

CEO Pay Ratio

78:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $14,957,319
Avg Employee Cost (SGA/emp): $191,893
Employees: 6,135

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
6,135
+38.7% YoY
Revenue / Employee
$375,895
Rev: $2,306,113,000
Profit / Employee
$-33,930
NI: $-208,160,000
SGA / Employee
$191,893
Avg labor cost proxy
R&D / Employee
$101,729
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -62.9% -82.8% -1.2% -1.5% -97.4% -80.6% -91.6% -98.4% -87.1% -59.1% -50.6% -40.8% -25.8% -19.4% -18.7% -24.3% -29.0% -14.3% -15.0% -12.5% -12.54%
ROA -35.6% -43.5% -53.6% -60.1% -47.0% -41.6% -44.3% -44.2% -40.7% -30.7% -26.2% -21.1% -14.1% -12.3% -11.9% -15.5% -18.1% -10.0% -10.4% -8.7% -8.71%
ROIC -2.6% -2.7% -2.2% -2.2% -1.7% -1.7% -1.5% -1.3% -1.4% -1.1% -86.0% -64.0% -44.3% -42.4% -40.4% -54.4% -70.5% -28.8% -27.7% -23.6% -23.63%
ROCE -35.7% -45.5% -58.8% -69.5% -72.3% -49.6% -52.0% -51.5% -42.1% -37.2% -30.3% -23.1% -15.5% -13.6% -13.2% -18.0% -22.1% -12.5% -13.5% -11.6% -11.62%
Gross Margin 48.5% 45.6% 46.8% 44.9% 44.7% 41.4% 38.7% 45.2% 45.1% 51.4% 56.7% 58.8% 61.8% 62.9% 63.2% 63.5% 64.9% 67.1% 64.8% 64.5% 64.46%
Operating Margin -95.0% -80.7% -70.6% -72.2% -56.5% -65.3% -57.2% -43.0% -41.4% -27.2% -20.2% -10.6% -8.9% -13.6% -15.8% -20.2% -16.5% -3.4% -13.4% -10.1% -10.07%
Net Margin -95.7% -81.2% -71.4% -73.2% -57.7% -65.6% -56.6% -42.4% -40.6% -25.1% -18.4% -9.1% -7.2% -11.3% -13.3% -18.5% -14.8% 7.1% -12.2% -8.9% -8.90%
EBITDA Margin -90.6% -78.3% -67.0% -68.0% -52.5% -60.6% -51.6% -37.9% -35.4% -20.7% -14.5% -6.2% -4.4% -9.7% -11.3% -16.4% -12.9% 1.2% -9.4% -6.0% -6.00%
FCF Margin -61.9% -60.2% -66.6% -66.9% -63.7% -58.4% -48.2% -41.6% -31.5% -26.4% -15.5% -7.9% -2.2% 4.1% 4.7% 5.3% 4.4% 4.2% 3.7% 2.6% 2.65%
OCF Margin -54.8% -53.6% -59.6% -60.5% -57.9% -52.6% -43.2% -36.8% -27.4% -22.9% -11.5% -4.2% 1.6% 8.0% 8.4% 9.5% 9.2% 9.3% 8.4% 8.4% 8.43%
ROE 3Y Avg snapshot only -21.93%
ROE 5Y Avg snapshot only -56.22%
ROA 3Y Avg snapshot only -13.64%
ROIC 3Y Avg snapshot only -85.75%
ROIC Economic snapshot only -11.41%
Cash ROA snapshot only 8.59%
Cash ROIC snapshot only 23.57%
CROIC snapshot only 7.40%
NOPAT Margin snapshot only -8.45%
Pretax Margin snapshot only -9.33%
R&D / Revenue snapshot only 29.09%
SGA / Revenue snapshot only 46.36%
SBC / Revenue snapshot only 10.67%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -25.31 -18.32 -7.12 -5.95 -7.79 -7.22 -11.36 -10.81 -10.21 -17.19 -30.23 -45.54 -73.19 -103.68 -100.41 -90.99 -71.42 -150.47 -125.04 -202.20 -301.728
P/S Ratio 18.26 13.82 5.83 4.73 5.48 4.82 7.15 5.94 5.15 6.90 9.14 9.78 10.26 11.63 10.41 11.73 10.43 13.58 11.32 14.37 21.709
P/B Ratio 13.59 13.23 7.17 7.70 11.76 5.60 9.54 9.28 6.49 9.76 13.91 15.90 17.89 16.52 15.37 18.49 17.64 18.29 15.95 21.35 32.278
P/FCF -29.52 -22.97 -8.75 -7.08 -8.61 -8.25 -14.83 -14.29 -16.36 -26.12 -59.10 -123.97 -473.50 285.13 223.67 220.37 236.02 324.19 307.56 542.46 542.465
P/OCF — — — — — — — — — — — — 637.40 145.53 124.45 123.41 113.65 145.48 134.11 170.41 170.405
EV/EBITDA -25.63 -18.33 -6.85 -5.86 -8.12 -6.90 -11.63 -11.24 -10.21 -18.36 -34.01 -53.96 -93.82 -131.24 -123.69 -104.89 -78.97 -141.80 -122.68 -212.35 -212.347
EV/Revenue 17.13 12.99 5.30 4.40 5.35 4.27 6.73 5.63 4.65 6.50 8.78 9.45 9.97 11.17 9.97 11.31 10.03 13.21 10.98 14.05 14.052
EV/EBIT -24.41 -17.56 -6.59 -5.62 -7.73 -6.51 -10.92 -10.48 -9.46 -16.68 -30.11 -46.28 -76.37 -105.90 -101.01 -89.99 -69.47 -118.12 -98.81 -155.58 -155.577
EV/FCF -27.70 -21.60 -7.97 -6.59 -8.40 -7.31 -13.95 -13.53 -14.78 -24.59 -56.73 -119.78 -460.05 273.85 214.33 212.53 226.85 315.27 298.35 530.57 530.567
Earnings Yield -4.0% -5.5% -14.1% -16.8% -12.8% -13.9% -8.8% -9.3% -9.8% -5.8% -3.3% -2.2% -1.4% -1.0% -1.0% -1.1% -1.4% -0.7% -0.8% -0.5% -0.49%
FCF Yield -3.4% -4.4% -11.4% -14.1% -11.6% -12.1% -6.7% -7.0% -6.1% -3.8% -1.7% -0.8% -0.2% 0.4% 0.4% 0.5% 0.4% 0.3% 0.3% 0.2% 0.18%
Price/Tangible Book snapshot only 29.460
EV/OCF snapshot only 166.668
EV/Gross Profit snapshot only 21.518
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 5.96 4.99 4.24 3.58 3.10 3.90 3.88 3.85 4.37 4.10 4.12 4.14 4.39 4.00 3.87 3.72 3.27 3.39 2.96 3.00 2.999
Quick Ratio 5.82 4.87 4.13 3.46 2.95 3.79 3.74 3.69 4.23 3.96 3.98 4.01 4.23 3.87 3.74 3.58 3.13 3.24 2.83 2.85 2.854
Debt/Equity 0.51 0.61 0.74 0.90 1.15 0.63 0.68 0.75 0.56 0.58 0.55 0.52 0.54 0.16 0.16 0.16 0.15 0.13 0.14 0.13 0.131
Net Debt/Equity -0.84 -0.79 -0.64 -0.53 -0.29 -0.64 -0.56 -0.49 -0.63 -0.57 -0.56 -0.54 -0.51 -0.65 -0.64 -0.66 -0.68 -0.50 -0.48 -0.47 -0.468
Debt/Assets 0.29 0.32 0.35 0.38 0.41 0.32 0.34 0.36 0.31 0.31 0.30 0.29 0.30 0.11 0.11 0.11 0.10 0.09 0.09 0.09 0.090
Debt/EBITDA -1.02 -0.90 -0.78 -0.74 -0.81 -0.88 -0.89 -0.95 -0.98 -1.15 -1.41 -1.84 -2.92 -1.30 -1.33 -0.93 -0.69 -1.00 -1.07 -1.33 -1.331
Net Debt/EBITDA 1.69 1.17 0.67 0.44 0.21 0.89 0.73 0.63 1.10 1.14 1.42 1.89 2.74 5.41 5.39 3.87 3.19 4.01 3.79 4.76 4.762
Interest Coverage -37.62 -55.72 -64.61 -67.50 -62.07 -57.68 -51.97 -44.17 -39.75 -33.38 -27.73 -21.96 -15.94 -16.76 -21.10 -38.18 -69.90 -25.21 -27.47 -24.51 -24.512
Equity Multiplier 1.73 1.89 2.11 2.40 2.79 1.98 2.03 2.09 1.84 1.88 1.85 1.81 1.81 1.39 1.40 1.41 1.45 1.46 1.47 1.46 1.459
Cash Ratio snapshot only 1.973
Debt Service Coverage snapshot only -17.959
Cash to Debt snapshot only 4.577
FCF to Debt snapshot only 0.301
Defensive Interval snapshot only 268.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.49 0.58 0.65 0.75 0.67 0.62 0.70 0.80 0.81 0.76 0.87 0.98 1.01 1.09 1.14 1.20 1.24 1.11 1.15 1.23 1.226
Inventory Turnover 11.74 13.57 14.56 13.18 12.36 14.64 15.25 14.63 13.72 15.49 14.36 15.01 14.29 15.76 14.97 15.30 13.56 14.32 14.39 13.95 13.954
Receivables Turnover 6.24 6.23 5.23 4.69 4.48 4.48 4.19 3.98 4.02 4.14 4.51 4.57 5.45 5.73 6.03 6.09 7.14 7.55 6.80 7.40 7.405
Payables Turnover 32.61 18.04 31.19 16.00 19.95 15.64 18.50 21.71 20.38 25.56 19.33 23.17 26.39 26.99 21.42 20.82 20.67 23.81 17.14 16.77 16.767
DSO 59 59 70 78 82 82 87 92 91 88 81 80 67 64 60 60 51 48 54 49 49.3 days
DIO 31 27 25 28 30 25 24 25 27 24 25 24 26 23 24 24 27 25 25 26 26.2 days
DPO 11 20 12 23 18 23 20 17 18 14 19 16 14 14 17 18 18 15 21 22 21.8 days
Cash Conversion Cycle 78 65 83 83 93 83 91 100 99 97 87 89 79 73 68 66 60 58 58 54 53.7 days
Fixed Asset Turnover snapshot only 6.053
Operating Cycle snapshot only 75.5 days
Cash Velocity snapshot only 2.480
Capital Intensity snapshot only 0.982
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 56.1% 60.0% 48.5% 43.3% 37.4% 31.1% 30.1% 28.7% 27.4% 32.0% 39.3% 46.1% 54.9% 56.7% 51.5% 44.4% 38.2% 35.9% 36.6% 37.8% 37.82%
Net Income -1.2% -1.1% -1.1% -82.9% -33.9% -16.1% 0.1% 11.1% 8.5% 20.6% 33.1% 42.9% 57.0% 56.2% 48.1% 13.3% -44.0% -9.3% -19.3% 24.0% 24.05%
EPS -89.0% -79.5% -91.9% -66.8% -27.7% -9.2% 14.5% 24.5% 22.9% 34.5% 38.1% 47.2% 60.0% 58.1% 53.4% 21.9% -29.9% 0.3% -13.6% 27.7% 27.70%
FCF -1.5% -86.2% -81.9% -72.6% -41.4% -27.4% 5.8% 19.9% 37.0% 40.3% 55.3% 72.3% 89.3% 1.2% 1.5% 2.0% 3.8% 39.5% 8.0% -31.4% -31.43%
EBITDA -1.3% -1.2% -1.2% -89.9% -35.3% -14.3% 2.9% 14.2% 11.8% 24.4% 37.9% 48.9% 63.9% 62.3% 52.7% 11.1% -65.2% -48.7% -51.6% 15.4% 15.44%
Op. Income -1.3% -1.2% -1.2% -85.1% -33.9% -15.6% 0.0% 10.3% 6.6% 17.5% 29.5% 38.7% 51.9% 50.2% 40.6% 6.4% -45.3% -39.4% -42.7% 1.3% 1.35%
OCF Growth snapshot only 22.25%
Asset Growth snapshot only 51.25%
Equity Growth snapshot only 46.17%
Debt Growth snapshot only 21.59%
Shares Change snapshot only 5.05%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 32.2% 34.4% 36.5% 38.3% 39.5% 39.5% 38.1% 39.7% 39.8% 40.4% 39.1% 39.2% 39.5% 39.5% 40.0% 39.5% 39.7% 41.1% 42.3% 42.7% 42.73%
Revenue 5Y 20.7% 23.6% 27.0% 28.8% 30.3% 31.2% 30.8% 31.6% 32.2% 33.3% 35.8% 37.8% 39.9% 41.2% 40.9% 41.9% 42.4% 42.6% 41.0% 39.9% 39.92%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y 49.2% 49.7% 49.6% 48.8% 46.5% 42.1% 34.0% 34.9% 34.5% 38.0% 39.5% 43.1% 46.6% 49.4% 53.6% 54.4% 56.3% 60.2% 64.4% 64.7% 64.66%
Gross Profit 5Y 25.2% 30.4% 36.8% 39.6% 40.0% 38.5% 35.6% 36.7% 38.0% 40.0% 45.4% 48.4% 51.1% 51.8% 49.3% 50.2% 50.7% 51.5% 48.7% 47.8% 47.85%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 67.8% 66.4% 63.6% 40.7% 38.4% 33.8% 33.2% 19.9% 14.0% 15.6% 18.0% 21.3% 6.7% 10.3% 14.8% 18.1% 21.8% 21.6% 25.6% 28.7% 28.66%
Assets 5Y 40.2% 42.5% 45.4% 46.4% 37.7% 45.4% 43.2% 45.0% 39.1% 40.0% 41.2% 31.7% 33.1% 23.3% 25.4% 19.4% 13.3% 21.9% 24.0% 25.6% 25.61%
Equity 3Y 1.4% 1.7% 3.8% 68.4% 62.2% 36.3% 35.9% 25.1% 13.5% 16.3% 28.7% 40.9% 5.0% 22.3% 31.7% 41.0% 51.3% 34.4% 39.7% 45.1% 45.11%
Book Value 3Y 1.1% 1.4% 3.2% 50.0% 45.8% 26.3% 20.7% 10.9% 0.9% 2.2% 15.2% 26.1% -4.7% 10.7% 17.5% 25.7% 34.8% 20.4% 29.1% 34.3% 34.34%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.74 0.76 0.84 0.85 0.86 0.88 0.91 0.92 0.93 0.93 0.94 0.93 0.91 0.90 0.91 0.92 0.93 0.93 0.93 0.93 0.928
Earnings Stability 0.66 0.66 0.62 0.69 0.78 0.82 0.81 0.82 0.86 0.77 0.59 0.40 0.21 0.10 0.04 0.01 0.00 0.13 0.22 0.40 0.399
Margin Stability 0.85 0.86 0.82 0.81 0.83 0.86 0.87 0.87 0.87 0.88 0.86 0.86 0.85 0.85 0.85 0.84 0.83 0.82 0.83 0.83 0.828
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 1.00 1.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.86 0.94 1.00 0.96 0.97 0.92 0.87 0.83 0.50 0.50 0.81 0.95 0.82 0.96 0.92 0.90 0.904
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 0.36 -0.26 -0.42 -0.52 -1.06 -0.18 0.01 0.31 0.39 0.18 0.46 0.73 0.83 0.51 0.50 0.40 0.19 0.24 0.18 0.17 0.171
Gross Margin Trend 0.06 0.04 -0.01 -0.02 -0.03 -0.04 -0.06 -0.05 -0.05 -0.01 0.06 0.09 0.14 0.15 0.16 0.15 0.13 0.12 0.09 0.07 0.069
FCF Margin Trend -0.31 -0.23 -0.27 -0.22 -0.14 -0.02 0.12 0.20 0.31 0.33 0.42 0.46 0.45 0.47 0.37 0.30 0.21 0.15 0.09 0.04 0.039
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.76 0.71 0.73 0.76 0.82 0.79 0.69 0.67 0.54 0.57 0.38 0.19 -0.11 -0.71 -0.81 -0.74 -0.63 -1.03 -0.93 -1.19 -1.187
FCF/OCF 1.13 1.12 1.12 1.10 1.10 1.11 1.12 1.13 1.15 1.16 1.34 1.89 -1.35 0.51 0.56 0.56 0.48 0.45 0.44 0.31 0.314
FCF/Net Income snapshot only -0.373
CapEx/Revenue 7.0% 6.6% 7.0% 6.3% 5.8% 5.8% 5.0% 4.8% 4.1% 3.6% 3.9% 3.7% 3.8% 3.9% 3.7% 4.2% 4.8% 5.1% 4.8% 5.8% 5.78%
CapEx/Depreciation snapshot only 2.395
Accruals Ratio -0.09 -0.13 -0.15 -0.14 -0.08 -0.09 -0.14 -0.15 -0.19 -0.13 -0.16 -0.17 -0.16 -0.21 -0.21 -0.27 -0.30 -0.20 -0.20 -0.19 -0.191
Sloan Accruals snapshot only -0.003
Cash Flow Adequacy snapshot only 1.458
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -5.6% -6.7% -14.8% -16.8% -0.5% -11.5% -7.2% -7.9% -8.6% -0.1% -0.1% -0.2% -0.2% -0.2% -0.1% -0.1% -0.1% -0.1% -0.2% -0.1% -0.14%
Total Shareholder Return -5.6% -6.7% -14.8% -16.8% -0.5% -11.5% -7.2% -7.9% -8.6% -0.1% -0.1% -0.2% -0.2% -0.2% -0.1% -0.1% -0.1% -0.1% -0.2% -0.1% -0.14%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.00 1.00 1.00 1.00 0.78 0.79 0.76 0.761
Interest Burden (EBT/EBIT) 1.03 1.02 1.02 1.01 1.02 1.02 1.02 1.02 1.03 1.03 1.04 1.05 1.06 1.06 1.05 1.03 1.01 1.04 1.03 1.03 1.033
EBIT Margin -0.70 -0.74 -0.81 -0.78 -0.69 -0.66 -0.62 -0.54 -0.49 -0.39 -0.29 -0.20 -0.13 -0.11 -0.10 -0.13 -0.14 -0.11 -0.11 -0.09 -0.090
Asset Turnover 0.49 0.58 0.65 0.75 0.67 0.62 0.70 0.80 0.81 0.76 0.87 0.98 1.01 1.09 1.14 1.20 1.24 1.11 1.15 1.23 1.226
Equity Multiplier 1.77 1.90 2.23 2.58 2.07 1.94 2.07 2.22 2.14 1.93 1.93 1.93 1.83 1.58 1.57 1.57 1.60 1.43 1.44 1.44 1.439
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-4.40 $-5.10 $-5.72 $-5.96 $-5.62 $-5.57 $-4.89 $-4.50 $-4.34 $-3.64 $-3.03 $-2.38 $-1.73 $-1.53 $-1.41 $-1.86 $-2.25 $-1.52 $-1.60 $-1.34 $-1.34
Book Value/Share $8.20 $7.06 $5.67 $4.60 $3.73 $7.17 $5.82 $5.24 $6.81 $6.42 $6.57 $6.81 $7.10 $9.58 $9.20 $9.14 $9.13 $12.52 $12.54 $12.71 $12.71
Tangible Book/Share $8.20 $7.06 $5.67 $4.60 $3.73 $7.17 $5.82 $5.24 $6.81 $6.42 $6.57 $6.81 $7.10 $9.58 $9.20 $9.14 $9.13 $8.76 $8.95 $9.21 $9.21
Revenue/Share $6.10 $6.76 $6.98 $7.49 $8.00 $8.33 $7.76 $8.19 $8.58 $9.07 $10.00 $11.07 $12.38 $13.61 $13.59 $14.40 $15.43 $16.87 $17.67 $18.89 $18.89
FCF/Share $-3.77 $-4.07 $-4.65 $-5.01 $-5.09 $-4.87 $-3.74 $-3.41 $-2.70 $-2.40 $-1.55 $-0.87 $-0.27 $0.56 $0.63 $0.77 $0.68 $0.71 $0.65 $0.50 $0.50
OCF/Share $-3.35 $-3.62 $-4.16 $-4.53 $-4.63 $-4.38 $-3.36 $-3.02 $-2.35 $-2.07 $-1.15 $-0.46 $0.20 $1.09 $1.14 $1.37 $1.42 $1.57 $1.49 $1.59 $1.59
Cash/Share $11.06 $9.88 $7.87 $6.61 $5.37 $9.13 $7.27 $6.47 $8.13 $7.37 $7.31 $7.22 $7.45 $7.76 $7.36 $7.45 $7.60 $7.87 $7.69 $7.62 $7.62
EBITDA/Share $-4.08 $-4.79 $-5.41 $-5.63 $-5.26 $-5.15 $-4.49 $-4.10 $-3.91 $-3.21 $-2.58 $-1.94 $-1.31 $-1.16 $-1.10 $-1.55 $-1.96 $-1.57 $-1.58 $-1.25 $-1.25
Debt/Share $4.16 $4.29 $4.22 $4.16 $4.29 $4.53 $3.99 $3.91 $3.84 $3.70 $3.64 $3.56 $3.84 $1.50 $1.45 $1.44 $1.35 $1.57 $1.70 $1.66 $1.66
Net Debt/Share $-6.90 $-5.59 $-3.65 $-2.45 $-1.08 $-4.59 $-3.28 $-2.57 $-4.29 $-3.66 $-3.67 $-3.66 $-3.61 $-6.26 $-5.91 $-6.01 $-6.25 $-6.30 $-5.99 $-5.95 $-5.95
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 27.586
Altman Z-Prime snapshot only 47.368
Piotroski F-Score 4 3 3 3 2 3 4 6 6 6 6 6 7 6 6 6 5 6 6 6 6
Beneish M-Score -2.33 -2.43 -2.07 -2.03 -1.78 -2.02 -2.61 -2.92 -3.14 -3.02 -2.96 -2.74 -2.48 -2.78 -3.14 -3.58 -3.50 1.30 0.41 0.43 0.428
Ohlson O-Score snapshot only -8.939
ROIC (Greenblatt) snapshot only -15.74%
Net-Net WC snapshot only $5.74
EVA snapshot only $-325687800.00
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A
Credit Score 56.49 56.81 44.74 34.79 33.99 40.05 53.76 50.11 50.27 61.36 61.39 61.41 61.33 72.94 72.82 71.93 71.88 73.01 71.71 72.87 72.875
Credit Grade snapshot only 6
Credit Trend snapshot only 0.945
Implied Spread (bps) snapshot only 150.000
Industry Credit Rank snapshot only 71
Sector Credit Rank snapshot only 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms